Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
2
2
0
0
Akili, Inc. - Common Stock
Share · US00974B1070 · AKLI (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Akili, Inc. - Common Stock
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 29,76 %
Shares Float 23,43 M
Shares Outstanding 78,73 M
Company Profile for Akili, Inc. - Common Stock Share
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Company Data
Name Akili, Inc. - Common Stock
Company Akili, Inc.
Symbol AKLI
Website
https://www.akiliinteractive.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US00974B1070
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Matthew Franklin
Market Capitalization 34 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 125 Broad Street, 02110 Boston
IPO Date 2021-06-30
ID Changes
| Date | From | To |
|---|---|---|
| 22.08.2022 | DNAA | AKLI |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | AKLI |
More Shares
Investors who hold Akili, Inc. - Common Stock also have the following shares in their portfolio:
